Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin

This article was originally published in The Tan Sheet

Executive Summary

High doses appear to inhibit immune cells in bone marrow related to autoimmune diseases, rejection of transplanted organs, suggesting new therapeutic use for analgesic, Holger Hackstein, MD, et al., University of Pittsburgh, report in Journal of Immunology June 15. Mouse study prompts researchers to plan follow-up research into organ transplant applications. Patients should not take high doses of aspirin after transplants based on current data, Hackstein et al. caution
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092641

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel